Appili Therapeutics Inc.

APLI.TOTSXHealthcare● Active

$0.02

+$0.00(+0.00%)

Market Cap$1925490

P/E Ratio—

52W High$0.04

52W Low$0.01

Avg Volume52K

Open$0.02

Beta-0.23

Cash on Hand Financials Revenue

Appili Therapeutics Inc. (APLI.TO) Cash on Hand — Cash & Short-Term Investments

Cash & cash equivalents plus short-term investments from the balance sheet, YoY change, and net cash vs debt context.

APLI.TO · cash on hand · updated Mar 31, 2025

Core cash position

as of Mar 31, 2025

Cash & Short-Term Investments (CCE + ST Investments)

$1.2M▲ +1199.8% vs prior year

FY · as of Mar 31, 2025 · Reported in CAD

Cash & Cash Equiv. (CCE)

$1.2M

cashAndCashEquivalents

Short-Term Investments

shortTermInvestments

YoY Change vs Prior Year

+1199.8%

vs prior fiscal year

Latest Quarter

$212,754

Q4 2025

Data Scope & Methodology

Cash on Hand = Cash & Cash Equivalents (CCE) + Short-Term Investments, as reported on the balance sheet (10-K/10-Q). Also referred to as cash reserves or cash position. Not free cash flow.

Source: FMP /balance-sheet-statement · SEC 10-K / 10-Q · Reported in CAD

Source: FMP /balance-sheet-statement · SEC 10-K / 10-Q · USDUpdated: March 31, 2025

Net cash vs debt

Cash vs Debt · Balance Sheet Health

Cash & ST Investments$1.2MCash on Hand

Total Debt$12.3MTotal Debt

Net Cash / Net Debt−$11.1MNet Debt Position

Cash vs Debt Ratio

Cash 9%Appili Therapeutics Inc. cash as % of market cap: 63.79%% · MCap $0BDebt 91%

Appili Therapeutics Inc. carries a net debt position of $11.1M. Total debt ($12.3M) exceeds cash on hand ($1.2M). Appili Therapeutics Inc. cash vs debt ratio: 9% cash / 91% debt.

Net Cash = Cash & ST Investments − Total Debt$1.2M − $12.3M = −$11.1M

Cash on hand history

annual cash on hand trend · Cash & Short-Term Investments

YoY Increase

YoY Decrease

Latest Year

APLI.TO annual cash on hand history · Cash & Short-Term Investments · Source: FMP /balance-sheet-statement

Annual cash on hand by year

APLI.TO cash & short-term investments history

DatePeriodCash & ST InvestmentsYoY Change

Mar 31, 2025LatestFY$1.2M+1199.8%

Mar 31, 2024FY$0.1M-96.2%

Mar 31, 2023FY$2.5M-63.0%

Mar 31, 2022FY$6.7M-58.7%

Mar 31, 2021FY$16.1M+53.0%

APLI.TO cash on hand annual historical data · Cash & Short-Term Investments per balance sheet (10-K/10-Q) · Reported in USD · Source: FMP /balance-sheet-statement

Healthcare Sector Cash Reserves Comparison

APLI.TO vs peers · cash on hand

#CompanyCash & ST Inv.Market CapCash/MCapRelative

UnitedHealth Group Incorporated

Eli Lilly and Company

Appili Therapeutics Inc.YOU

APLI.TO

$1.2M$2M63.8%

Healthcare sector cash reserves · Source: FMP /balance-sheet-statement + /profile · Sorted by Cash desccompanies with most cash on hand →

About cash on hand & methodology

Appili Therapeutics Inc. (APLI.TO) cash on hand as of March 31, 2025 is $1.2M, comprising $1.2M in cash and cash equivalents (CCE) plus $0 in short-term investments — reported as Appili Therapeutics Inc. cash and short-term investments on the balance sheet (10-K filing). Also referred to as Appili Therapeutics Inc. cash reserves or cash position.

Appili Therapeutics Inc. annual cash on hand history shows increased +1199.8% in 2025: increased +1199.8% in 2025. Appili Therapeutics Inc. cash reserves in 2025 reflect the company's capital allocation strategy.

Appili Therapeutics Inc. carries total debt of $12.3M against cash of $1.2M, resulting in a net debt position of -$11.1M. For the full balance sheet, see the Financials → Balance Sheet tab.

Figures tie to SEC 10-K/10-Q balance sheet disclosures and FMP /balance-sheet-statement where noted.

Financial statements Free cash flow Net income Revenue Market cap P/E ratio Earnings Price history

Frequently asked questions

APLI.TO cash on hand · 5 questions

As of March 31, 2025, Appili Therapeutics Inc. (APLI.TO) has $1,228,244 in cash on hand — defined as cash and short-term investments on the balance sheet. This includes $1,228,244 in cash and cash equivalents (CCE) plus $0 in short-term investments. Latest quarter (December 31, 2025): $212,754. Data sourced from the annual 10-K filing via FMP.

APLI.TO cash on handAPLI.TO cash reservesAPLI.TO cash 2025how much cash does APLI.TO have

▸ Source: FMP /balance-sheet-statement · US GAAP · Appili Therapeutics Inc. · Appili Therapeutics Inc. SEC 10-K & 10-Q filings · US GAAP · Last updated: March 31, 2025